Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Dutasteride inhibits both Type I and Type II 5-alpha reductase enzymes (finasteride only inhibits Type II), producing more complete DHT suppression in scalp tissue. Applied topically, it achieves local follicle DHT reduction while minimizing systemic effects.
No FDA-approved topical dutasteride exists. Oral dutasteride (Avodart) is FDA-approved for BPH but carries the same systemic anti-androgen side effects as oral finasteride. Compounded topical dutasteride delivers superior DHT blockade locally with lower systemic absorption.
Compare up to 7,500 pharmacies across the USA.
Dutasteride provides more complete DHT suppression than finasteride because it inhibits both isoforms of 5-alpha reductase (Type I and Type II), versus finasteride which only inhibits Type II. Oral dutasteride reduces serum DHT by up to 99% compared to finasteride’s 70%.
Topically applied, dutasteride achieves this superior DHT reduction in scalp follicles while keeping systemic levels far below those of oral dosing — reducing the risk of sexual side effects, mood changes, and post-dutasteride syndrome.
Topical dutasteride is frequently combined with topical minoxidil in a single daily application for comprehensive dual-mechanism hair loss treatment.
Androgenetic alopecia (male and female pattern hair loss), particularly in cases where topical finasteride was insufficient; patients wanting maximum DHT blockade with minimal systemic exposure
Topical solution (0.02–0.1%): Apply 1mL to affected scalp once daily
Combination (dutasteride + minoxidil): Apply once or twice daily
Allow 6–12 months for full assessment
Reduced vs. oral dutasteride. Possible scalp irritation. Some systemic absorption still occurs — rare sexual side effects reported at higher concentrations over large scalp areas.
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
